The rising costs in medications have been a driving force in reform for the American healthcare system. Debates over healthcare in the U.S. came to a head this fall when Martin Shkreli, the CEO of KaloBios Pharmaceuticals, hiked up the price of a prescription medication often used to treat AIDS from $13.50 to $750 per…